Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...
Главные авторы: | Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Wiley
2018-07-01
|
Серии: | Reproductive Medicine and Biology |
Предметы: | |
Online-ссылка: | https://doi.org/10.1002/rmb2.12209 |
Схожие документы
-
Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
по: Vakkas Korkmaz, и др.
Опубликовано: (2013-08-01) -
Results of surgical treatment of atypical endometrial hyperplasia
по: O. A. Gornykh, и др.
Опубликовано: (2014-07-01) -
Modern approaches to the diagnosis of endometrial hyperplasia
по: M. M. Damirov, и др.
Опубликовано: (2025-02-01) -
Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
по: А. E. Protasova, и др.
Опубликовано: (2024-07-01) -
Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
по: An-Ju Chou, и др.
Опубликовано: (2024-11-01)